Integrated Analysis of Gene Copy Number, Copy Neutral LOH, and microRNA Profiles in Adult Acute Lymphoblastic Leukemia

We adopted an integrated analysis of gene copy number alterations (CNAs), copy number neutral loss of heterozygosity (CNN LOH), and microRNA (miRNA) profiling in 21 adult acute lymphoblastic leukemia (ALL) patients. This study revealed the most frequent CNAs to be at chromosomes 9p, 7, and 17 and recurrent CNN LOH at 5p, 9p, and Xq. As for the most differentially expressed miRNAs, they included 8 upregulated and 14 downregulated miRNAs, of which miR-148a at 7p15.2, miR-22 at 17p13.3, miR-223 at Xq12, as well as miR-101-2 at 9p24.1 exhibited recurrent CNAs or CNN LOH. miR-101-2 was recurrently downregulated, and although the related CNN LOH was detected only in BCR-ABL1 negative cases (2/14), deletions of miR-101-2 were observed solely in BCR-ABL1 positive cases (4/7). Finally, BCR-ABL1 positive cases, in contrast to negative ones, were characterized by slightly, but still significantly, higher expression levels of miR-29b.

[1]  J. Burchenal,et al.  Treatment of acute lymphoblastic leukemia. , 1972, Annual review of medicine.

[2]  J. Harbott,et al.  Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects , 1998, Leukemia.

[3]  M. Schrappe,et al.  Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia , 1999, Oncogene.

[4]  Michael Baudis,et al.  Progenetix.net: an online repository for molecular cytogenetic aberration data , 2001, Bioinform..

[5]  J. Bourhis,et al.  Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial. , 2002, Blood.

[6]  Anton J. Enright,et al.  MicroRNA targets in Drosophila , 2003, Genome Biology.

[7]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[8]  A. Hall,et al.  Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. , 2005, Cancer research.

[9]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[10]  A. Hall,et al.  Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course. , 2005, Cancer research.

[11]  S. Armstrong,et al.  Molecular genetics of acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[13]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[14]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.

[15]  T. Golub,et al.  MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.

[16]  G. Gores,et al.  mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.

[17]  J. Hehir-Kwa,et al.  High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression , 2007, Leukemia.

[18]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[19]  F. Ross,et al.  Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization , 2007, Oncogene.

[20]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[21]  Samuel Myllykangas,et al.  CanGEM: mining gene copy number changes in cancer , 2007, Nucleic Acids Res..

[22]  S. Plon,et al.  Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia , 2008, Pediatric blood & cancer.

[23]  Å. Borg,et al.  Array‐CGH reveals hidden gene dose changes in children with acute lymphoblastic leukaemia and a normal or failed karyotype by G‐banding , 2008, British journal of haematology.

[24]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[25]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[26]  S. Knuutila,et al.  CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study. , 2008, Leukemia research.

[27]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[28]  J. Cigudosa,et al.  Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. , 2008, Cancer cell.

[29]  R. Pieters,et al.  Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. , 2008, Blood.

[30]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[31]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[32]  Hui Zhou,et al.  Genome-Wide Analysis of Small RNA and Novel MicroRNA Discovery in Human Acute Lymphoblastic Leukemia Based on Extensive Sequencing Approach , 2009, PloS one.

[33]  G. Mills,et al.  Uniparental disomy in cancer. , 2009, Trends in molecular medicine.

[34]  D. Basso,et al.  Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks , 2009, Genes, chromosomes & cancer.

[35]  Ralf Herwig,et al.  ConsensusPathDB—a database for integrating human functional interaction networks , 2008, Nucleic Acids Res..

[36]  M. D. Boer,et al.  Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia , 2009, Leukemia.

[37]  S. Knuutila,et al.  Acute lymphoblastic leukemias with normal karyotypes are not without genomic aberrations. , 2009, Cancer genetics and cytogenetics.

[38]  K. Zatloukal,et al.  miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis , 2009, EMBO reports.

[39]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[40]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[41]  Jianjun Chen,et al.  MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. , 2010, Blood cells, molecules & diseases.

[42]  S. Ogawa,et al.  Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia , 2010, Haematologica.

[43]  R. Foà,et al.  Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study , 2010, British journal of haematology.

[44]  S. Knuutila,et al.  Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data. , 2010, Leukemia research.

[45]  A. Moorman,et al.  A population-based cytogenetic study of adults with acute lymphoblastic leukemia. , 2010, Blood.

[46]  S. Knuutila,et al.  Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single‐nucleotide polymorphism microarray analyses , 2009, Genes, chromosomes & cancer.

[47]  Xian-Ming Chen,et al.  Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation , 2010, British journal of haematology.

[48]  I. Weissman,et al.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia , 2010, The Journal of experimental medicine.

[49]  I. Weissman,et al.  microRNA-29 a induces aberrant self-renewal capacity in hematopoietic progenitors , biased myeloid development , and acute myeloid leukemia , 2010 .

[50]  Song Liu,et al.  Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia. , 2010, Cancer genetics and cytogenetics.

[51]  H. Kantarjian,et al.  New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia , 2011, Leukemia & lymphoma.

[52]  E. van den Berg,et al.  Microarray‐based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia , 2011, Genes, chromosomes & cancer.

[53]  C. V. D. Schoot,et al.  Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia , 2011, Leukemia.

[54]  S. Knuutila,et al.  MicroRNA microarrays on archive bone marrow core biopsies of leukemias--method validation. , 2011, Leukemia research.

[55]  B. Johansson,et al.  High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome , 2012, Genes, chromosomes & cancer.